In a 2025 study of HT patients without orbitopathy, over half exhibited objective DED, and nearly half of these had severe symptoms, yet anti-TPO titers showed no consistent correlation with subjective (OSDI) or objective (Schirmer and NIBUT) measures of DED [4]. This evidence concerns the gene TPO and hematocrit.